|
注册号: Registration number: |
ChiCTR2000033499 |
|
最近更新日期: Date of Last Refreshed on: |
2020-06-05 02:07:11 |
|
注册时间: Date of Registration: |
2020-06-03 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
请与我们联系上传伦理批件 传统与导航辅助下行一期双侧全膝关节置换术疗效分析 |
|
Public title: |
Computer-Navigated compared with Conventional Total Knee Arthroplasty in Patients Undergoing One-Stage Bilateral Surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
传统与导航辅助下行一期双侧全膝关节置换术疗效分析 |
|
Scientific title: |
Computer-Navigated compared with Conventional Total Knee Arthroplasty in Patients Undergoing One-Stage Bilateral Surgery |
|
研究课题代号(代码): Study subject ID: |
81873990 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
朱锋 |
研究负责人: |
徐耀增 |
|
Applicant: |
Feng Zhu |
Study leader: |
Yaozeng Xu |
|
申请注册联系人电话: Applicant telephone: |
+86 15051427236 |
研究负责人电话:
Study leader's |
+86 13706213287 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
925521767@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
xuyaozeng@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省苏州市十梓街188号 |
研究负责人通讯地址: |
江苏省苏州市十梓街188号 |
|
Applicant address: |
188 Shizi Street, Suzhou, China |
Study leader's address: |
188 Shizi Street, Suzhou, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
苏州大学附属第一医院 |
||
|
Applicant's institution: |
the First Affiliated Hospital of Soochow University |
||
|
研究负责人所在单位: |
苏州大学附属第一医院 |
||
|
Affiliation of the Leader: |
the First Affiliated Hospital of Soochow University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
N/A |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
苏州大学附属第一医院医学伦理委员会 |
||
|
Name of the ethic committee: |
the First Affiliated Hospital of Soochow University ethic committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
苏州大学附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
the First Affiliated Hospital of Soochow University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省苏州市十梓街188号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
188 Shizi Street, Suzhou, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金面上项目,大麻素受体2在激素性股骨头坏死修复中的作用及机制研究(81873990),2019/01-2022/12,57万元 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China, the role of cannabinoid receptors in the process of SANFH repair and mechanism research(81873990), 2019/01-2022/12, 570,000 yuan |
||||||||||||||||||||||
|
研究疾病: |
膝关节炎 |
||||||||||||||||||||||
|
Target disease: |
knee arthritis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(1)对比传统与导航辅助下TKA的早中期临床疗效差异 (2)归纳导航辅助TKA学习曲线,完成自身前后对照并不断反馈优化 (3)建立多学科协作TKA围手术期患者加速康复的管理模式 (4)归纳导航TKA手术经验及标准化流程建立 |
||||||||||||||||||||||
|
Objectives of Study: |
(1)compare the early to mid terms of clinical difference between the traditional and computer-navigated total knee arthroplasty (2)determine the learning curve of navigated TKA (3)establish the pattern of enhanced recovery after surgery (4)summarize the experience and protocol of naviagated TKA |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
患者罹患严重心肺等基础疾病严重影响术后康复者;因髋关节、足踝病变及外伤等因素致术后无法完成正常功能锻炼者;因帕金森综合症,脑梗病史等疾病导致患者长期卧床、下肢肌肉废用性萎缩者;既往膝关节手术史及膝关节周围骨折病史。 |
||||||||||||||||||||||
|
Exclusion criteria: |
patients with severe cardiopulmonary diseases; disfunction to exercise after surgery caused by hip, ankle diseases or trauma, etc; lower limb muscle disused atrophy caused by Parkinson's disease or cerebral infarction; previous knee surgery or peri-knee joint fracture history |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2019-06-01 00:00:00至 To 2023-06-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2019-06-01 00:00:00 至 To 2022-12-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究者利用电脑随机数字表随机分配,并置于信封中,于手术室中术前打开 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
computer-generated study number in a sealed envelope, which was opened in the operating room before the skin incision was made |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
临床试验公共管理平台 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan (www.medresman.org) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
Not stated |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Not stated |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |